Phenotype–genotype analysis of 242 individuals with RASopathies: 18‐year experience of a tertiary center in Brazil

We report the clinical and molecular data of a large cohort comprising 242 individuals with RASopathies, from a single Tertiary Center in Brazil, the largest study from Latin America. Noonan syndrome represented 76% of the subjects, with heterozygous variants in nine different genes, mainly PTPN11,...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of medical genetics. Part C, Seminars in medical genetics Vol. 184; no. 4; pp. 896 - 911
Main Authors Bertola, Débora R., Castro, Matheus A. A., Yamamoto, Guilherme L., Honjo, Rachel S., Ceroni, José Ricardo, Buscarilli, Michele M., Freitas, Amanda B., Malaquias, Alexsandra C., Pereira, Alexandre C., Jorge, Alexander A. L., Passos‐Bueno, Maria Rita, Kim, Chong A.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2020
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1552-4868
1552-4876
1552-4876
DOI10.1002/ajmg.c.31851

Cover

More Information
Summary:We report the clinical and molecular data of a large cohort comprising 242 individuals with RASopathies, from a single Tertiary Center in Brazil, the largest study from Latin America. Noonan syndrome represented 76% of the subjects, with heterozygous variants in nine different genes, mainly PTPN11, SOS1, RAF1, LZTR1, and RIT1, detected by Sanger and next‐generation sequencing. The latter was applied to 126 individuals, with a positive yield of 63% in genes of the RAS/MAPK cascade. We present evidence that there are some allelic differences in PTPN11 across distinct populations. We highlight the clinical aspects that pose more medical concerns, such as the cardiac anomalies, bleeding diathesis and proliferative lesions. The genotype–phenotype analysis between the RASopathies showed statistically significant differences in some cardinal features, such as craniofacial and cardiac anomalies, the latter also statistically significant for different genes in Noonan syndrome. We present two individuals with a Noonan syndrome phenotype, one with an atypical, structural cardiac defect, harboring variants in genes mainly associated with isolated hypertrophic cardiomyopathy and discuss the role of these variants in their phenotype.
Bibliography:Funding information
Conselho Nacional de Desenvolvimento Científico e Tecnológico, Grant/Award Numbers: 301871/2016‐7, 303375/2019‐1, 304852/2016‐3; Fundação de Amparo à Pesquisa do Estado de São Paulo, Grant/Award Numbers: 2011/17299‐3, 2013/08028‐1
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1552-4868
1552-4876
1552-4876
DOI:10.1002/ajmg.c.31851